Wednesday, Oct 18, 2023 · SEC filings
What the smart money revealed on Oct 18
312 insider filings came in. We hid 54 planned (10b5-1) sellers and 167 people whose filings were routine, like grants and tax withholding.
Cerevel Therapeutics (CERE) Director Christopher Gordon bought $125M
5.48M shares on the open market. Not a grant or an option exercise.
Scholar Rock Holding (SRRK) Director Srinivas Akkaraju bought $15M
2.19M shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 7 checked quarters beat the typical stock 6 months later.
Asana (ASAN) President Dustin Moskovitz bought $5.23M
280,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 4 checked quarters beat the typical stock 6 months later.
Solitron Devices (SODI) COO Mark Matson bought $208K
19,482 shares on the open market. Not a grant or an option exercise.
DoorDash (DASH) Director Stanley Tang sold $14.1M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 88,364 shares directly.
AutoZone (AZO) Sr. Vice President Albert Saltiel sold $5.83M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 537 shares directly.
Ferguson (FERG) Senior VP of Supply Chain Michael Jacobs sold $863K
Not marked as a planned 10b5-1 sale. Sold 94% of the shares they held directly. Still holds 319 shares.
Show 17 more real buys
Show 40 more real sales
13F season
Holdings as of Sep 30, 2023 are due Nov 14
40 funds have filed so far. 40 filed for the quarter before.
Biggest real insider buys, Oct 12–18
Open-market buys by officers and directors, filed in the 7 days up to Oct 18.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.